Skip to content

Clinical trials

Phase 3 Cardiovascular Diseases trials in Thailand

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiovascular Diseases Phase: Phase 3 Country / region: Thailand Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20071
20081
20091
20111
20122
20132
20141
20151
20171
20181
20232
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Terminated5
Active, not recruiting2
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline4
Novartis Pharmaceuticals3
Pfizer2
AstraZeneca1
Boehringer Ingelheim1
CSL Behring1
Hoffmann-La Roche1
National Institute of Allergy and Infectious Diseases (NIAID)1
Novo Nordisk A/S1
Sanofi1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiovascular Diseases17
Myocardial Infarction6
Stroke5
Atherosclerosis4
Diabetes Mellitus, Type 24
Acute Coronary Syndrome3
Heart Diseases3
Hyperlipidemias3
Coronary Artery Disease2
Coronary Disease2

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.